Related Experiment Videos
Haemophilus influenzae: surface antigens and aspects of virulence
1Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri.
Insights
Haemophilus influenzae type b conjugate vaccines, targeting polyribosylribitol phosphate (PRP), are more effective in young children. Further research into noncapsular antigens may lead to improved vaccines and treatments for invasive diseases.
Area of Science:
- Bacteriology
- Immunology
- Vaccinology
Background:
- Haemophilus influenzae type b (Hib) causes severe invasive diseases, particularly bacterial meningitis, in young children.
- The type b capsular polysaccharide, polyribosylribitol phosphate (PRP), is a key virulence factor but poorly immunogenic in infants.
- Noncapsular surface antigens like lipooligosaccharide (LOS) and outer membrane proteins (OMPs) may also contribute to Hib virulence.
Purpose of the Study:
- To review the role of surface antigens in Haemophilus influenzae type b virulence.
- To discuss the development and efficacy of conjugate vaccines against Hib.
- To explore potential targets for future vaccine and therapeutic strategies.
Main Methods:
- Review of existing literature on Hib surface antigens and virulence factors.
- Analysis of studies on the immunogenicity and efficacy of Hib vaccines.
- Examination of research on noncapsular antigens and their role in disease.
Main Results:
- Polysaccharide-protein conjugate vaccines significantly enhance immunogenicity and efficacy in young children compared to plain polysaccharide vaccines.
- Antibodies against certain noncapsular antigens, including specific OMPs (98K, P1, P2, P6), confer protection in animal models.
- The role of antibodies against LOS in protection is less clear due to antigenic variation.
Conclusions:
- Characterization of the Hib capsular polysaccharide has led to disease prevention.
- Further understanding of noncapsular antigens and virulence mechanisms is crucial for developing improved Hib vaccines and treatments.
- Targeting multiple surface antigens may offer enhanced protection against invasive Hib disease.
Abstract:
Haemophilus influenzae type b is a major cause of bacterial meningitis and other invasive diseases in children under four years of age. One surface antigen, the type b capsular polysaccharide, polyribosylribitol phosphate (PRP), is a primary virulence factor of the organism. Antibody directed against PRP is protective; however, the purified polysaccharide is poorly immunogenic in young children. Polysaccharide-protein conjugate vaccines have been prepared which are significantly more immunogenic and efficacious in young children compared to the plain polysaccharide vaccine. Noncapsular surface antigens may also play a role in the virulence of H. influenzae. Some mutants (or phase variants) which differ in lipooligosaccharide (LOS) structure exhibit decreased virulence in the infant rat model of bacteremia. Proteins including the IgA protease, pili, a 98K outer membrane protein (OMP) as well as OMPs P1, P2 and P6 have also been examined in considerable detail, but whether they have a role in the virulence of the organism remains to be determined. However, antibody directed against the 98K OMP as well as P1, P2 and P6 is protective in the infant rat model of bacteremia. The role of antibody directed against LOS epitopes in protection is less clear, due at least in part, to phase variation in LOS antigens. Characterization of one surface antigen of H. influenzae type b, the capsular polysaccharide, already has led to the prevention of many cases of Haemophilus disease. Characterization of the noncapsular antigens together with a more detailed understanding of the mechanisms of virulence, most likely will permit development of even better vaccines, and possibly better treatment modalities, in the future.